These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 12370860

  • 1. Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation.
    Bondanelli M, Ambrosio MR, Margutti A, Boldrini P, Basaglia N, Franceschetti P, Zatelli MC, Degli Uberti EC.
    Metabolism; 2002 Oct; 51(10):1363-9. PubMed ID: 12370860
    [Abstract] [Full Text] [Related]

  • 2. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone.
    Bondanelli M, Ambrosio MR, Margutti A, Franceschetti P, Zatelli MC, degli Uberti EC.
    Neuroendocrinology; 2003 Jun; 77(6):380-7. PubMed ID: 12845224
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [Abstract] [Full Text] [Related]

  • 4. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [Abstract] [Full Text] [Related]

  • 5. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
    Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD.
    Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380
    [Abstract] [Full Text] [Related]

  • 6. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
    Colao A, Cerbone G, Pivonello R, Aimaretti G, Loche S, Di Somma C, Faggiano A, Corneli G, Ghigo E, Lombardi G.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1277-82. PubMed ID: 10199767
    [Abstract] [Full Text] [Related]

  • 7. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P, Isidro L, Leal-Cerro A, Casanueva FF, Dieguez C, Cordido F.
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [Abstract] [Full Text] [Related]

  • 8. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L, Maccario M, Lanfranco F, Ramunni J, Di Vito L, Grottoli S, Muller EE, Ghigo E, Arvat E.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [Abstract] [Full Text] [Related]

  • 9. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
    Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
    [Abstract] [Full Text] [Related]

  • 10. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, Aimaretti G, Ghigo E.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [Abstract] [Full Text] [Related]

  • 11. Provocative hypothalamopituitary axis tests in severe head injury: correlations with severity and prognosis.
    Della Corte F, Mancini A, Valle D, Gallizzi F, Carducci P, Mignani V, De Marinis L.
    Crit Care Med; 1998 Aug; 26(8):1419-26. PubMed ID: 9710103
    [Abstract] [Full Text] [Related]

  • 12. The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men.
    Haijma SV, van Dam PS, de Vries WR, Maitimu-Smeele I, Dieguez C, Casanueva FF, Koppeschaar HP.
    Eur J Endocrinol; 2005 Apr; 152(4):575-80. PubMed ID: 15817913
    [Abstract] [Full Text] [Related]

  • 13. Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity.
    Pincelli AI, Rigamonti AE, Scacchi M, Cella SG, Cappa M, Cavagnini F, Müller EE.
    Eur J Endocrinol; 2003 Feb; 148(2):237-43. PubMed ID: 12590644
    [Abstract] [Full Text] [Related]

  • 14. Control of growth hormone secretion from porcine fetal and neonatal pituitary tissue in vitro by growth hormone-releasing hormone, somatostatin, and insulin-like growth factor.
    Torronteras R, Gracia-Navarro F, Elsaesser F.
    Neuroendocrinology; 1997 Feb; 65(2):117-28. PubMed ID: 9067989
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone in obesity.
    Scacchi M, Pincelli AI, Cavagnini F.
    Int J Obes Relat Metab Disord; 1999 Mar; 23(3):260-71. PubMed ID: 10193871
    [Abstract] [Full Text] [Related]

  • 16. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E, Gianotti L, Arvat E, Ramunni J, Valetto MR, Broglio F, Rolla M, Cavagnini F, Müller EE.
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [Abstract] [Full Text] [Related]

  • 17. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G, Baffoni C, Bellone S, Di Vito L, Corneli G, Arvat E, Benso L, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [Abstract] [Full Text] [Related]

  • 18. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
    Bernardi F, Petraglia F, Seppala M, Spinetti A, Bertolini S, Ferdeghini M, Genazzani AR.
    Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
    [Abstract] [Full Text] [Related]

  • 19. Hypothalamic derangement in traumatized patients: growth hormone (GH) and prolactin response to thyrotrophin-releasing hormone and GH-releasing hormone.
    De Marinis L, Mancini A, Valle D, Bianchi A, Gentilella R, Liberale I, Mignani V, Pennisi M, Della Corte F.
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):741-7. PubMed ID: 10468946
    [Abstract] [Full Text] [Related]

  • 20. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome.
    Moorkens G, Berwaerts J, Wynants H, Abs R.
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):99-106. PubMed ID: 10931086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.